Sell This Stock… But HOLD Our FDA Catalyst Trade

Posted On Sep 11, 2014 By Rick Pearson

We were right! Contrave got FDA approval. But what gives?


Subscribe to Kinetic Profits Today!

Kinetic Profits uses an arsenal of computing power to give you a statistical edge over Wall Street. Our proprietary Archimedes trading platform finds a stock's strongest periods year after year — and alerts you instantly so you can act on that information. Our real-world tests show that Archimedes can successfully identify upward moves in stocks with 93.5% accuracy. Now's the time to harness the power of this "quant" system for yourself.

Subscribe Today!